Cynthia Hornacek

Title: Cynthia Hornacek: Innovator in Proteolytic Enzyme Compositions

Introduction

Cynthia Hornacek is a notable inventor based in Trabuco Canyon, California. She has made significant contributions to the field of proteolytic enzyme compositions, particularly in the context of tissue digestion and cell isolation. With a total of 3 patents to her name, her work has implications for medical advancements, especially in artificial vessel grafts.

Latest Patents

Cynthia's latest patents focus on methods for isolating cells from tissue using specific enzyme compositions. One of her patents describes a method that includes collagenase, which is free of toxins and non-collagen specific components, and chymopapain, also free of toxins. These enzyme compositions are essential for dissociating microvessel cells from connective tissue. The recovered microvessel cells can then be incorporated into artificial vessel grafts. The preferred composition contains collagenase with an activity of about 43 nkat/ml to about 51 nkat/ml and chymopapain with an activity of about 0.22 nkat/ml to about 0.44 nkat/ml.

Career Highlights

Cynthia Hornacek is currently employed at Baxter International Inc., where she continues to innovate in her field. Her work has been instrumental in developing new methods that enhance the efficiency of cell recovery from connective tissues.

Collaborations

Cynthia collaborates with talented coworkers such as Tan T Dinh and Catherine T Lee, contributing to a dynamic research environment that fosters innovation.

Conclusion

Cynthia Hornacek's contributions to the field of proteolytic enzyme compositions highlight her role as a significant inventor. Her patents not only advance scientific understanding but also pave the way for practical applications in medical technology.